Junko Yarimizu

A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.

Katsuya Harada, Kazuhiro Nakato, Takayuki Yamaji, 2012, European journal of pharmacology.

Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates

Makoto Asai, M. Asai, Keni Ni, 2014, Neuropharmacology.